SignalPET Elevates Leadership Team and Announces Strategic Expansion
August 14, 2024 08:00 ET
|
SignalPET
Dallas, TX, Aug. 14, 2024 (GLOBE NEWSWIRE) -- SignalPET, a medical technology innovator in the veterinary industry, proudly announces two pivotal leadership changes, bolstering the launch of a...
SignalPET Announces New Initiative to Empower Veterinary Graduates
July 16, 2024 08:00 ET
|
SignalPET
Dallas, TX, July 16, 2024 (GLOBE NEWSWIRE) -- SignalPET, a leading veterinary technology company, just announced a groundbreaking new Graduate Incentive program designed to nurture the next...
SignalPET Has Launched a Rapid Veterinary Radiology Service, SignalSTAT, combining AI and Human Oversight to Improve Speed of Care & Patient Outcomes
January 09, 2024 08:00 ET
|
SignalPET
Dallas, TX, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Veterinary radiology company, SignalPET has launched their new product, SignalSTAT, which seamlessly blends cutting-edge AI technology with human...
New to The Street Re-signs PetVivo Holdings, Inc. for another 12-Month TV Media Series; Agreement Includes Commercials and Billboard Ads
December 20, 2023 09:30 ET
|
FMW Media Works Corp
New to The Street Re-signs PetVivo Holdings, Inc. for another 12-Month TV Media Series; Agreement Includes Commercials and Billboard Ads
AAHA Announces Enhanced Digital Benchmarking Platform – Now Free for All Members
December 08, 2023 14:48 ET
|
American Animal Hospital Association
Lakewood, CO, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The American Animal Hospital Association (AAHA) is proud to partner with Chewy Health to provide its comprehensive analytics platform, AAHA...
Research Proves Assisi Animal Health’s Calmer Canine® Clinically Resolves Canine Separation Anxiety
January 11, 2022 11:23 ET
|
Assisi Animal Health
New York, NY, Jan. 11, 2022 (GLOBE NEWSWIRE) -- A recent study conducted by North Carolina State University conclusively demonstrates that Assisi Animal Health’s targeted pulsed electromagnetic...
LexaGene Closes Multiple MiQLab Sales
December 03, 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Finalizes Design of Pneumonia Panel
November 01, 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit
October 27, 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene Reports on Recent Veterinary Trade Shows
September 30, 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...